You searched for: Idogen
Idogen about the conference in Boston and the plans ahead
Christina Herder, acting CEO of the biotechnology company Idogen, joined BioStock's studio to talk about the company's participation at the 6th...
Idogen one of ten companies selected for world-leading meeting
The biotechnology company Idogen was invited to participate in The Guthy Jackson Charitable Foundation's "20rd Summit for NMOSD Tolerization" on January 22-3...
VILDA – new network for female leaders in life science
In December 2022, Anna Törner, Cecilia Bröms-Thell and Sarah Lidé announced that they were starting a new network for women...
Idogen strengthens fund for clinical study in 2023
The subscription period has now begun in Idogen's rights issue, which will enable continued development within the spearhead program IDO 8 in patients with...
The value of patent protection in life science
Inventing, developing and launching new pharmaceuticals and medical devices is a long, capital-intensive and risky process. Ownership and...
BioStock Life Science Fall Summit - see all features!
For the fifth year, we invited you to the BioStock Life Science Summit and now you can see all the features here!...
Idogen strengthens the board with Jan Holgersson
Idogen strengthens the board with Professor Jan Holgersson, who has extensive experience in immunology and has also been involved...
Idogen's acting CEO comments on the share issue
The biotechnology company Idogen is in the clinical phase with the cell therapy program IDO 8, which aims to restore the effect of factor VIII...
First hemophilia patient enters Idogen's study
The first patient with hemophilia A has now been included in Idogen's clinical phase I/IIa study with the company's cell therapy within IDO...
Exciting times for Idogen's new chairman of the board
On September 6, an extraordinary general meeting was held in Idogen where Joakim Söderström and Niklas Wallett were elected as chairmen of the board...
BioStock Investor Meeting: Interview with Idogen
In connection with the BioStock Investor Meeting in Stockholm, BioStock took the opportunity to interview Christina Herder, Idogen's newly appointed interim CEO....
Erika Samuelsson new CDO at Cyxone
At the beginning of the autumn, First North company Cyxone announced that it had recruited Erika Samuelsson as new Chief Development Officer with...